Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma
Open Access
- 23 April 2014
- journal article
- research article
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 3 (1) , 12
Abstract
Mesothelin, a mesothelial marker, has been found expressed in and as a potential treatment target of cholangioacarcinoma (CC). It is possible that CC may be derived from the cells sharing mesothelial markers. However, the expression of other mesothelial markers in CC is largely unknown.Keywords
This publication has 65 references indexed in Scilit:
- Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinomaLaboratory Investigation, 2013
- Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculatureNature Cell Biology, 2012
- Identification of a novel developmental mechanism in the generation of mesotheliaDevelopment, 2012
- Arginase-1, HepPar-1, and Glypican-3 Are the Most Effective Panel of Markers in Distinguishing Hepatocellular Carcinoma From Metastatic Tumor on Fine-Needle Aspiration SpecimensAmerican Journal of Clinical Pathology, 2012
- Calretinin Staining Facilitates Differentiation of Olfactory Neuroblastoma From Other Small Round Blue Cell Tumors in the Sinonasal TractAmerican Journal of Surgical Pathology, 2011
- Advances in Liver Cancer Antibody TherapiesBioDrugs, 2011
- CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinomaBMC Cancer, 2011
- Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 casesLaboratory Investigation, 2009
- Cytoplasmic Staining of TTF-1 in the Differential Diagnosis of Hepatocellular Carcinoma vs Cholangiocarcinoma and Metastatic Carcinoma of the LiverAmerican Journal of Clinical Pathology, 2006
- Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificityLaboratory Investigation, 2006